| Product Code: ETC12803503 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Israel continued to import HIV injections primarily from Switzerland, UK, Belgium, USA, and Germany. The market maintained low concentration levels with a Herfindahl-Hirschman Index (HHI) indicating a competitive landscape. Despite a slight decline in the Compound Annual Growth Rate (CAGR) from 2020 to 2024 at -2.14%, the market showed signs of stability with a marginal growth rate of -0.41% from 2023 to 2024. This data suggests a steady demand for HIV injections in Israel, with diversified sources of imports contributing to the market`s resilience.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel HIV Injection Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel HIV Injection Market Revenues & Volume, 2021 & 2031F |
3.3 Israel HIV Injection Market - Industry Life Cycle |
3.4 Israel HIV Injection Market - Porter's Five Forces |
3.5 Israel HIV Injection Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Israel HIV Injection Market Revenues & Volume Share, By Administration Route, 2021 & 2031F |
3.7 Israel HIV Injection Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Israel HIV Injection Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel HIV Injection Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Israel HIV Injection Market Trends |
6 Israel HIV Injection Market, By Types |
6.1 Israel HIV Injection Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Israel HIV Injection Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Israel HIV Injection Market Revenues & Volume, By Antiretroviral Injections, 2021 - 2031F |
6.1.4 Israel HIV Injection Market Revenues & Volume, By Pre-Exposure Prophylaxis (PrEP) Injections, 2021 - 2031F |
6.1.5 Israel HIV Injection Market Revenues & Volume, By Long-Acting Injectable Therapy, 2021 - 2031F |
6.1.6 Israel HIV Injection Market Revenues & Volume, By Post-Exposure Prophylaxis (PEP) Injections, 2021 - 2031F |
6.2 Israel HIV Injection Market, By Administration Route |
6.2.1 Overview and Analysis |
6.2.2 Israel HIV Injection Market Revenues & Volume, By Intramuscular (IM) Injections, 2021 - 2031F |
6.2.3 Israel HIV Injection Market Revenues & Volume, By Subcutaneous (SC) Injections, 2021 - 2031F |
6.3 Israel HIV Injection Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel HIV Injection Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Israel HIV Injection Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.4 Israel HIV Injection Market Revenues & Volume, By Home Care, 2021 - 2031F |
6.4 Israel HIV Injection Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Israel HIV Injection Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.3 Israel HIV Injection Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 Israel HIV Injection Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Israel HIV Injection Market Import-Export Trade Statistics |
7.1 Israel HIV Injection Market Export to Major Countries |
7.2 Israel HIV Injection Market Imports from Major Countries |
8 Israel HIV Injection Market Key Performance Indicators |
9 Israel HIV Injection Market - Opportunity Assessment |
9.1 Israel HIV Injection Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Israel HIV Injection Market Opportunity Assessment, By Administration Route, 2021 & 2031F |
9.3 Israel HIV Injection Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Israel HIV Injection Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel HIV Injection Market - Competitive Landscape |
10.1 Israel HIV Injection Market Revenue Share, By Companies, 2024 |
10.2 Israel HIV Injection Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here